Accium Early Drug Development Partnerships

The use of AMS in early drug development research continues to grow and new applications are continually being developed.  Accium has the expertise, experience and operations to perform all aspects of AMS analysis. 

To assist our clients in the development and execution of clinical trials Accium BioSciences has formed partnerships with the leading clinical CROs, radiolabel synthesis providers, pharmacokinetics modelers and regulatory compliance consultants to offer a turnkey operation.

Our clients have the flexibility to contract a clinical study through Accium or through our partners. 

Quintiles Transnational

Quintiles Phase I services brings together an unequaled breadth and depth of experience and services. We offer unrivaled expertise for safe, innovative, early-phase human drug development to Good Clinical Practice and Good Laboratory Practice standards.

All Quintiles Phase I units combine superb healthcare and analytical facilities with the complex amenities needed to attract, house and motivate volunteers. The specialized staff at each site includes physicians, pharmaceutical scientists, nurses, investigators, analysts and pharmacokineticists with experience in numerous therapeutic areas. Each unit has established its own reputation for excellence and its own loyal client base.

PRA International                                                                              

PRA is one of the world’s leading clinical development organizations with more than 2,700 employees worldwide providing reliable service delivery, program-level therapeutic expertise, easy global access to knowledge and involved senior management to our customers.

Over the past 25 years, PRA has earned the confidence of the pharmaceutical and biotechnical industries through our unique approach we call Project Assurance^®: A company-wide commitment to consistently achieve customers’ requirements everywhere in PRA.

CMIC (Japan)

The CMIC Group consists of fourteen companies, including CMIC Co., Ltd. and consolidated affiliates. The Group's businesses mainly involve support for the pharmaceutical industry. Instead of making drugs, we offer comprehensive services related to drug, all the processes of a pharmaceuticals company from research and development to manufacture and sale. Leveraging our experience and expertise as a pioneer CRO, our business has expanded to create added value in such fields as drugs, medical devices, specific functional foods, and so on. Moreover, we are tackling the service which is useful to "the medical treatment for a patient" also in the field of medical treatment and healthcare, strengthening customer service as "PVC (Pharmaceutical Value Creator)" which contributes for value maximization of a pharmaceuticals company.

The main service areas include: Monitoring, Data management, CRC business, Pharmaceutical affairs consulting and Pre-clinical work.

Charles River Laboratories Clinical Services

Northwest Kinetics

Northwest Kinetics is the premier early phase clinical pharmacology unit in the Pacific Northwest. Our clinical pharmacology unit offers advanced technological abilities and a full range of services and for both short and long-term Phase 0, I and II trials.

Northwest Kinetics operates in a built-to-suit facility designed for successful execution and completion of early phase clinical trials to the highest of standards. We pay careful attention to every customer detail, proactively anticipating and responding to potential issues, and fostering lasting client partnerships.

On October 31, 2006, Charles River Laboratories acquired Northwest Kinetics. Charles River establishes a Phase I Clinical Services capacity in North America, which in conjunction with its Phase I facility in Edinburgh, Scotland, positions it exceptionally well to support its clients’ high-end clinical pharmacology studies. Between the two state-of-the-art facilities, Charles River will have over 200 beds, with an additional 100 beds currently being added to the Tacoma facility.

BattelleCRO

BattelleCRO is a Contract Research Organization with broad expertise in the planning, execution and interpretation of clinical trials. BattelleCRO serves as a partner in clinical research excellence - one with extensive experience in product development services.
 

For the last decade, the scientific community has relied on BattelleCRO with confidence, knowing that we deliver uncompromising quality and performance in the planning, execution and interpretation of clinical trials. Whether you are a Pharmaceutical, Biotech or Medical Device company, BattelleCRO delivers the experience and partnership that are vital to your organizations needs. Our company is driven by results-oriented professionals who thrive on our clients' success and work tirelessly to deliver the highest standards of clinical research for each and every trial.

Analytical Bio-Chemistry Laboratories (ABC)

Analytical Bio-Chemistry Laboratories' mission is to be a premier provider of development services to the pharmaceutical and chemical industries. Analytical Bio-Chemistry Laboratories enables clients to realize higher profits and reduce development risk while accelerating time to market.

Radiolabeled (¹⁴C) GMP API for early clinical trials - Projects are conducted in conformance with the company's NRC approved Radiation Safety Program and are overseen by an experienced Radiation Safety Officer approved by the NRC. ABC has had an NRC license since the early 1970s and the most recent inspection was October 2002. The inspection was routine and there were no reportable findings.